SciELO - Scientific Electronic Library Online

 
vol.58 issue5Transrectal protatic biopsy guidelines for patients older than 50 years in relation to PSA elaborated by a mathematical decision treeCerebellum and lower urinary tract author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Archivos Españoles de Urología (Ed. impresa)

Print version ISSN 0004-0614

Abstract

ARES VALDES, Yolanda  and  FRAGAS VALDES, Ramiro. Incidental renal cell carcinoma. Arch. Esp. Urol. [online]. 2005, vol.58, n.5, pp.417-420. ISSN 0004-0614.

OBJECTIVES: To report the incidence and management of incidental renal cell carcinoma (RCC). METHODS: We performed a retrospective longitudinal and panel study for our case series between January 1990 and December 2003. Thirty cases of RCC were analyzed, 6 of which were incidental. RESULTS: 4 patients were males (66.6%) and 2 females (33.3%); age ranged between 28 and 72 years. Reason for consultation was related with gastrointestinal symptoms. Ultrasound and CT scan are the most useful studies. Clinical stage was 4 T1(66.6%), 2 T2 (33.3%). 4 radical nephrectomies and 2 conservative surgeries (partial nephrectomy and tumorectomy) were performed. A dose of 3 million units of alpha 2b recombinant interferon (IFN alpha 2b r) was given Intramuscularly two times a week over 6 months. Follow-up ranged between 120 and 60 months and none of the patients had evidence of tumor activity. CONCLUSIONS: The incidence of incidental RCC in our hospital is 20%. Clinical stage was always low and survival is directly related to stage. Conservative surgery showed similar survival than radical surgery.

Keywords : Renal cell carcinoma; Incidental; Survival; Stage; Interferon.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License